Now a generic antiviral drug initially targeting influenza in Japan, the original maker of the product, FUJIFILM Toyama Chemical Co., Ltd. calls the drug Avigan. Sales…
FUJIFILM Toyama Chemical Co., Ltd. (FUJIFILM Toyama Chemical; President: Junji Okada) has announced the initiation of a new phase III clinical trial in Japan concerning…
Japanese drug regulatory authorities failed to make a decision on whether favipiravir (Avigan) would be used as a treatment for COVID-19 alongside remdesivir (Gilead’s Veklury)…
A Kuwait-based clinical trial sponsored by Indian generic drug producer Dr. Reddy’s Laboratory was recently terminated as the resulting data failed to evidence a statistically…
Yet another nation has opted to embrace the antiviral drug Favipiravir (Avigan) as a treatment for early onset COVID-19. Approved in Japan for influenza (and…
Health Canada may be following India, Russia, some nations in Eastern Europe, and dozens of other nations who opt to use the antiviral medication Favipiravir…
Japanese health authorities are struggling to reach a decision as to whether favipiravir (Avigan) is effective as treatment for COVID-19 based on the results of…
Publicly traded Appili Therapeutics out of Canada, a biotech venture attempting to commercialize Avigan® tablets (favipiravir), the antiviral drug originating from Japan that has been…
Glenmark Pharmaceuticals, a prominent Indian pharmaceutical firm, reports that the oral antiviral drug originating in Japan, Favipiravir, prevents the replication phase of SARS-CoV-2, the virus…
Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug development, today announced that it has signed…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
